Literature DB >> 8904926

Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48.

A Curtin1, P Deegan, D Owens, P Collins, A Johnson, G H Tomkin.   

Abstract

The role of the intestine in cholesterol metabolism in human diabetes is unclear, although abnormalities have been demonstrated in cholesterol synthesis and absorption in diabetic animals. This study examines the relationship between fasting and post-prandial apolipoprotein B-48 in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Eight type 2 diabetic patients and ten healthy non-diabetic control subjects were given a high-fat meal (1300 kcal), and the triglyceride-rich lipoprotein fraction was isolated by ultracentrifugation (d < 1.006 g/ml) from fasting and post-prandial plasma. Apolipoprotein B-48 and apo B-100 were separated on 4%-15% gradient gels and quantified by densitometric scanning with reference to a purified low-density lipoprotein (LDL) apo B-100 preparation. Diabetic patients had significantly higher concentrations of apo B-48 and apo B-100 in both the fasting (P < 0.05) and post-prandial (P < 0.001) triglyceride-rich lipoprotein samples compared with non-diabetic subjects. The diabetic patients also exhibited a significantly different post-prandial profile for apo B-48 and apo B-100, with a prolonged increase and a later post-prandial peak, than the non-diabetic subjects (P < 0.01). These results suggest that the raised fasting triglyceride-rich lipoproteins, often found in diabetes, are associated with apo B-48 and may be derived from increased intestinal chylomicron production. The post-prandial pattern suggests an abnormality in intestinal production as well as hepatic clearance of apo B-48 in type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904926     DOI: 10.1007/bf02048544

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  31 in total

1.  Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine.

Authors:  J M Hoeg; D D Sviridov; G E Tennyson; S J Demosky; M S Meng; D Bojanovski; I G Safonova; V S Repin; M B Kuberger; V N Smirnov
Journal:  J Lipid Res       Date:  1990-10       Impact factor: 5.922

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

3.  Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins.

Authors:  S D Krasinski; J S Cohn; E J Schaefer; R M Russell
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine.

Authors:  L M Powell; S C Wallis; R J Pease; Y H Edwards; T J Knott; J Scott
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

5.  Lipid and apolipoprotein B48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats.

Authors:  I J Martins; A J Sainsbury; J C Mamo; T G Redgrave
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

6.  Cholesterol metabolism in alloxan-induced diabetic rabbits.

Authors:  N M O'Meara; R A Devery; D Owens; P B Collins; A H Johnson; G H Tomkin
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

7.  Alterations in apolipoprotein B-48 in the postprandial state in NIDDM.

Authors:  A Curtin; P Deegan; D Owens; P Collins; A Johnson; G H Tomkin
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

Review 8.  Disordered gastric motor function in diabetes mellitus.

Authors:  M Horowitz; R Fraser
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

9.  Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants.

Authors:  S D Krasinski; J S Cohn; R M Russell; E J Schaefer
Journal:  Metabolism       Date:  1990-04       Impact factor: 8.694

10.  Contributions of absorbed dietary cholesterol and cholesterol synthesized in small intestine to hypercholesterolemia in diabetic rats.

Authors:  N L Young; D R Lopez; D J McNamara
Journal:  Diabetes       Date:  1988-08       Impact factor: 9.461

View more
  19 in total

1.  Robert Graves Memorial Lecture. Diabetes and atherosclerosis--a gut review.

Authors:  G H Tomkin
Journal:  Ir J Med Sci       Date:  2002 Apr-Jun       Impact factor: 1.568

Review 2.  Hyperglycaemia: the relation to dyslipidaemia and atherosclerosis.

Authors:  G H Tomkin
Journal:  Ir J Med Sci       Date:  2002 Jul-Sep       Impact factor: 1.568

3.  Comparison of diets high in monounsaturated versus polyunsaturated fatty acid on postprandial lipoproteins in diabetes.

Authors:  C Madigan; M Ryan; D Owens; P Collins; G H Tomkin
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

Review 4.  Potential of Glucagon-Like Peptide 1 as a Regulator of Impaired Cholesterol Metabolism in the Brain.

Authors:  Young-Kook Kim; Juhyun Song
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

Review 5.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

6.  Jejunal wall triglyceride concentration of morbidly obese persons is lower in those with type 2 diabetes mellitus.

Authors:  F Soriguer; S García-Serrano; L Garrido-Sánchez; C Gutierrez-Repiso; G Rojo-Martínez; E Garcia-Escobar; J García-Arnés; J L Gallego-Perales; V Delgado; Eduardo García-Fuentes
Journal:  J Lipid Res       Date:  2010-09-20       Impact factor: 5.922

Review 7.  ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety.

Authors:  Alison B Kohan; Fei Wang; Chun-Min Lo; Min Liu; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-15       Impact factor: 4.052

8.  The effect of exercise on postprandial lipidemia in type 2 diabetic patients.

Authors:  L W L Tobin; B Kiens; H Galbo
Journal:  Eur J Appl Physiol       Date:  2007-10-20       Impact factor: 3.078

9.  Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids.

Authors:  Mirjana Pavlic; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

10.  Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.

Authors:  Hélène Duez; Benoît Lamarche; René Valéro; Mirjana Pavlic; Spencer Proctor; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Circulation       Date:  2008-04-28       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.